BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26918620)

  • 1. Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages.
    Pawelek KA; Dor D; Salmeron C; Handel A
    PLoS One; 2016; 11(2):e0150568. PubMed ID: 26918620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced viral infectivity and reduced interferon production are associated with high pathogenicity for influenza viruses.
    Li K; McCaw JM; Cao P
    PLoS Comput Biol; 2023 Feb; 19(2):e1010886. PubMed ID: 36758109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
    Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.
    Perrone LA; Plowden JK; GarcĂ­a-Sastre A; Katz JM; Tumpey TM
    PLoS Pathog; 2008 Aug; 4(8):e1000115. PubMed ID: 18670648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL/6J but not BALB/c mice.
    Otte A; Gabriel G
    Virulence; 2011; 2(6):563-6. PubMed ID: 22030859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
    Hatta Y; Hershberger K; Shinya K; Proll SC; Dubielzig RR; Hatta M; Katze MG; Kawaoka Y; Suresh M
    PLoS Pathog; 2010 Oct; 6(10):e1001139. PubMed ID: 20949022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.
    Kiso M; Ozawa M; Le MT; Imai H; Takahashi K; Kakugawa S; Noda T; Horimoto T; Kawaoka Y
    J Virol; 2011 May; 85(10):4667-72. PubMed ID: 21367898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.
    Lee SM; Gardy JL; Cheung CY; Cheung TK; Hui KP; Ip NY; Guan Y; Hancock RE; Peiris JS
    PLoS One; 2009 Dec; 4(12):e8072. PubMed ID: 20011590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1.
    Sakabe S; Takano R; Nagamura-Inoue T; Yamashita N; Nidom CA; Quynh Le Mt; Iwatsuki-Horimoto K; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(2):262-71. PubMed ID: 23042757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models.
    Otte A; Sauter M; Alleva L; Baumgarte S; Klingel K; Gabriel G
    Am J Pathol; 2011 Jul; 179(1):230-9. PubMed ID: 21703405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
    Zhao D; Liang L; Wang S; Nakao T; Li Y; Liu L; Guan Y; Fukuyama S; Bu Z; Kawaoka Y; Chen H
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin.
    Cline TD; Karlsson EA; Freiden P; Seufzer BJ; Rehg JE; Webby RJ; Schultz-Cherry S
    J Virol; 2011 Dec; 85(23):12262-70. PubMed ID: 21917948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine response and viral replication in mouse bone marrow derived macrophages infected with influenza H1N1 and H5N1 viruses.
    Chan RW; Leung CY; Nicholls JM; Peiris JS; Chan MC
    PLoS One; 2012; 7(11):e51057. PubMed ID: 23226456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice.
    Morrison J; Josset L; Tchitchek N; Chang J; Belser JA; Swayne DE; Pantin-Jackwood MJ; Tumpey TM; Katze MG
    J Virol; 2014 Sep; 88(18):10556-68. PubMed ID: 24991006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H5N1 virus causes significant perturbations in host proteome very early in influenza virus-infected primary human monocyte-derived macrophages.
    Cheung CY; Chan EY; Krasnoselsky A; Purdy D; Navare AT; Bryan JT; Leung CK; Hui KP; Peiris JS; Katze MG
    J Infect Dis; 2012 Sep; 206(5):640-5. PubMed ID: 22822004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus.
    Yasui F; Itoh Y; Ikejiri A; Kitabatake M; Sakaguchi N; Munekata K; Shichinohe S; Hayashi Y; Ishigaki H; Nakayama M; Sakoda Y; Kida H; Ogasawara K; Kohara M
    Sci Rep; 2016 Nov; 6():37915. PubMed ID: 27892498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.
    Nakayama M; Shichinohe S; Itoh Y; Ishigaki H; Kitano M; Arikata M; Pham VL; Ishida H; Kitagawa N; Okamatsu M; Sakoda Y; Ichikawa T; Tsuchiya H; Nakamura S; Le QM; Ito M; Kawaoka Y; Kida H; Ogasawara K
    PLoS One; 2013; 8(12):e82740. PubMed ID: 24376571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.